Clinical trials
Diabetes (Insulin-requiring, Type 1 or Type 2) clinical trials
Below are recruiting diabetes (insulin-requiring, type 1 or type 2) clinical trials, each written for real people, not researchers. We’re tracking 2,155 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07498218RecruitingPhase 1
Studying VELGRAFT for diabetic foot ulcers
This trial tests a new treatment called VELGRAFT, which is made from living cells, for diabetic foot ulcers that haven't healed with standard care. The goal is to see if it can help the wound close and heal more effectively.
Phoenix, ArizonaAges 18 years+ - NCT07114445Enrolling by invitation
Virtual reality foot care training for type 2 diabetes
This trial tests if using virtual reality glasses to teach foot care can help people with type 2 diabetes take better care of their feet. It aims to prevent serious foot problems.
Gaziantep, GaziantepAges 18 years+ - NCT06195228RecruitingPhase 4
Real-world study of genetic types in advanced thyroid cancer
This study looks at how different genetic types of advanced thyroid cancer respond to treatment in real-world settings. It may help doctors choose the best therapy for you based on your tumor’s genetic makeup.
Fuzhou, FujianAges Any age - NCT07565727Recruiting
Heart Health and Metabolism in Early Pregnancy
This study looks at how the body processes sugar and nutrients during pregnancy in women at higher risk for pre-eclampsia (a serious pregnancy condition with high blood pressure). Researchers want to understand if taking low-dose aspirin helps protect heart and metabolic health. You'll have blood tests, body composition scans, and metabolic measurements.
Knoxville, TennesseeAges 18–45 - NCT07403604RecruitingPhase 1
Lowering Insulin to Reduce Fat Buildup in the Liver
This study tests if lowering insulin levels can reduce fat buildup in the liver for people with a fatty liver condition called MASLD. It's looking for adults who are overweight and have early signs of insulin resistance but not diabetes.
New York, New YorkAges 18–65 - NCT07263438RecruitingPhase 2
Trimipramine, atezolizumab, and bevacizumab for recurrent glioblastoma
This trial tests a combination of three drugs—trimipramine (an antidepressant), atezolizumab (an immunotherapy), and bevacizumab (a targeted therapy)—in people whose glioblastoma has come back after initial treatment. The goal is to see if this mix can help shrink the tumor or slow its growth.
Basel, BaselAges 18 years+ - NCT05868733RecruitingPhase 2
Lassa fever vaccine study for people in West Africa
This trial tests an investigational vaccine to prevent Lassa fever, a serious illness found in parts of West Africa. People in different age groups will get the vaccine or a placebo and be followed to see if it’s safe and helps the immune system respond.
AccraAges 1.5 years–70 years - NCT07117240Enrolling by invitationPhase 4
GLP-1 drugs for steroid-induced diabetes
This trial tests whether a GLP-1 receptor agonist (a type of diabetes medication) can safely and effectively treat high blood sugar caused by long-term steroid use. It may help people with type 2 diabetes or steroid-induced diabetes who take oral steroids for conditions like asthma, arthritis, or kidney disease.
Warsaw, WarsawAges 18 years+ - NCT06542718Recruiting
Studying glucose patterns in Asian women with gestational diabetes
This study monitors blood sugar levels during pregnancy in overweight Asian women to better understand gestational diabetes. It uses a continuous glucose monitor to track patterns and may help improve care for mothers and babies.
SingaporeAges 21–45 - NCT07210515RecruitingPhase 3
Testing Ambros Therapy for Early CRPS
This trial tests if an intravenous medicine called AMBTX-01 (neridronate) can help people with early-stage Complex Regional Pain Syndrome (CRPS) type 1. It focuses on those whose affected limb feels warm, looks red, and is swollen.
Phoenix, ArizonaAges 18 years+ - NCT07857733RecruitingPhase 3
Extended treatment study for complex regional pain syndrome
This study gives an extended course of neridronate infusions to people who completed the earlier AMBTX-01-301 trial, to see if longer treatment safely keeps easing their chronic pain and other symptoms of complex regional pain syndrome (a long-lasting pain condition, often after an injury).
Phoenix, ArizonaAges 18 years+ - NCT04286399RecruitingPhase 4
Prevention trial for heart outcomes in people with type 2 diabetes
This Phase 4 trial studies an approach to help prevent heart problems in adults with type 2 diabetes who are at higher heart risk. It may help reduce future cardiovascular events by testing medications for safety and benefit in this group.
SingaporeAges 40 years+ - NCT05331105RecruitingPhase 2
Drug for adults with NF1 and non-surgically treatable nerve tumors
This Phase 2 trial tests HL-085 in adults with neurofibromatosis type 1 (NF1) who have a nerve tumor (plexiform neurofibroma) that cannot be removed by surgery and causes symptoms. It aims to shrink or control the tumor by measuring changes on MRI and monitoring side effects.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07867080RecruitingPhase 3
Gene therapy injection for diabetic macular edema
This trial tests a one-time gene therapy injection into the eye for adults with diabetic macular edema (DME), a condition where fluid builds up in the retina and blurs vision. The goal is to reduce the need for frequent eye injections and help maintain vision over time.
Scottsdale, ArizonaAges 18 years+ - NCT07812090RecruitingPhase 2
Oral medication for diabetic macular edema
This study tests an oral medication that may reduce swelling in the retina caused by diabetes. If you have diabetic macular edema affecting your central vision, this trial could help you preserve or improve your sight.
McAllen, TexasAges 18–75 - NCT07803835RecruitingPhase 1
Study of MWX401 for healthy adults and mild high blood pressure
This study tests a new medicine, MWX401, to see if it is safe and how it works in the body. It includes healthy adults and people with mild high blood pressure, with frequent check-ups to ensure safety.
Nanjing, JiangsuAges 18–60 - NCT07781917Recruiting
Comparison of two treatments for diabetic foot ulcers
This study compares two treatments for diabetic foot ulcers that haven't healed with standard care. It aims to see which treatment is more effective in helping these wounds close.
DhakaAges 18–75 - NCT07679204Recruiting
Personality and life satisfaction in bipolar and depression
This study looks at how personality traits and life satisfaction affect people with bipolar II disorder or major depression. You will fill out questionnaires about your feelings and daily life.
ElâzığAges 18 years+ - NCT07526272Recruiting
Magnesium membrane versus bone graft for tooth implants
This study compares two methods to rebuild bone around immediate tooth implants (implants placed right after tooth extraction). The goal is to see which material—a magnesium membrane or bone graft—works better to support the implant and maintain bone structure.
GizaAges Any age - NCT06192940Recruiting
Smart insulin pens and quality of life in diabetes
This study tests if smart insulin pens that connect to continuous glucose monitors can improve quality of life for people with diabetes who need help managing their treatment. If you use multiple daily injections, a glucose sensor, and rely on a healthcare provider, this trial may help find better ways to manage your condition.
Corbeil-Essonnes, FranceAges 18 years+ - NCT07273721RecruitingPhase 2
Testing BT200 in type 2B von Willebrand disease
This trial tests a new medicine called BT200 (rondaptivon pegol) to see if it can safely help people with type 2B von Willebrand disease who have low platelets and recent bleeding problems.
Vienna, State of ViennaAges 18 years+ - NCT07221292RecruitingPhase 3
Study of N-acetyl-L-leucine for CACNA1A disorders
This trial tests a potential treatment for people with CACNA1A disorders, which can cause movement problems, migraine, or seizures. The medication may help improve balance and coordination.
Baltimore, MarylandAges 4 years+ - NCT07143773RecruitingPhase 4
SGLT2i safety in kidney transplant patients without diabetes
This study tests whether a medicine called SGLT2i (a type of pill for kidney health) is safe and helpful for kidney transplant recipients who do not have diabetes. It aims to see if it can improve how the new kidney works.
OdenseAges 18 years+ - NCT07079761RecruitingPhase 2
PTSD treatment study with a hormone-like drug
This trial tests if a single infusion of allopregnanolone (a natural brain chemical) can help people with PTSD reduce fear responses and improve memory processing. It may offer a new way to treat PTSD by targeting how the brain stores traumatic memories.
Boston, MassachusettsAges 18–55
Hear when a new Diabetes (Insulin-requiring, Type 1 or Type 2) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes (insulin-requiring, type 1 or type 2)?
- Yes. Clin2 currently lists 2,155 recruiting diabetes (insulin-requiring, type 1 or type 2) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes (insulin-requiring, type 1 or type 2) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes (insulin-requiring, type 1 or type 2) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.